Thomas O'Brien is listed as a director on 2 SEC Form D filings by 1 issuer in Nov 2009: Revolutions Medical CORP (Charleston, SC — biotechnology — 2009; $1.05M reported sold to 43 investors).
What this means One deal on file with the SEC, filed Nov 2009. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Rondald L. Wheet (2 shared filings) and Thomas Beahm (2 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Thomas. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Thomas O'Brien and found 11 differences, 2 worth asking the sponsor about: Regulator action naming a team member: Revolutions Medical Corp., et al. (Mar 21, 2018); Regulator action naming a team member: Revolutions Medical Corp. and Rondald L. Wheet (Sep 21, 2012); and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.